Introduction {#h0.0}
============

*Streptococcus pneumoniae* is an important human pathogen and is well known for expressing diverse polysaccharide (PS) capsules ([@B1]) that are considered to be essential for its pathogenicity ([@B2], [@B3]). Extensive studies have identified more than 90 serologically distinct capsules ([@B1], [@B4]). The capsular polysaccharide synthesis (*cps*) locus, which contains the genes necessary for capsule production and is flanked by *dexB* and *aliA* genes, has been characterized for all serotypes ([@B1], [@B5], [@B6]). Despite such a close association between pneumococcal pathogenesis and the capsule, some pneumococcal isolates show no serological evidence for capsule expression. These nontypeable (NT) "pneumococcal" isolates (i.e., bacteria satisfying the conventional definition but without the multilocus sequence typing \[MLST\]-based definition of *S. pneumoniae*) have been associated with infectious conjunctivitis ([@B7]), occasional invasive pneumococcal diseases (IPD) ([@B8]--[@B10]), otitis media ([@B11], [@B12]), and nasopharyngeal (NP) carriage ([@B8]). Also, the prevalence of NT pneumococcal isolates appears to be increasing (from 1.5% in 2001 to 5.1% in 2006) following the use of a very effective conjugate vaccine ([@B13]).

Despite its increase in prevalence ([@B13]), little is known about NT "pneumococci." A major issue is that some of them may not even be *S. pneumoniae*. Traditionally, *S. pneumoniae* has been identified as alpha-hemolytic colonies that are optochin sensitive and have genes such as *lytA* and *ply*. However, these traditional chemical or genetic tests can fail to distinguish *S. pneumoniae* from other closely related species in the mitis group, which includes *Streptococcus mitis*, *Streptococcus pseudopneumoniae*, and *Streptococcus oralis* as well as *S. pneumoniae* ([@B14]--[@B16]). This difficulty in species identification can now be addressed, since it was recently found that the MLST analysis that examines the sequences of 7 different housekeeping gene loci can be used to reliably distinguish pneumococci from closely related species ([@B17]--[@B19]).

Using NT "pneumococci" that were typed only by traditional means, one study found two groups of *cps* among them: groups I and II ([@B8]). Group I NT isolates have the *cps* locus sequences of conventional capsule types ([@B8]), but their *cps* appears to be too disrupted (e.g., *cpsE* duplication) to produce capsular PS ([@B20]). Group II isolates lack all the genes usually found in the *cps* sequences of encapsulated *S. pneumoniae* isolates, but their *cps* contains an *aliB*-like ORF1 or *aliB*-like ORF2 ([@B8]), which appear to encode lipoproteins ([@B8]) and which are referred to here as *aliC* and *aliD* for simplicity. Since this study was performed before the use of MLST for species identification, many of these NT "pneumococci" may not be *S. pneumoniae* by MLST analysis ([@B17], [@B21], [@B22]). Moreover, the study reporting group I and group II isolates examined only European isolates. We were additionally interested in the possibility that the group II isolates from different regions might show additional diversity in their *cps* regions. We therefore studied 52 group II isolates from different continents for their MLST and *cps* diversity. Our study found a new subset of group II isolates containing a novel gene, *pspK*, which is necessary for nasopharyngeal carriage in mice.

RESULTS {#h1}
=======

Identification of group II NT "pneumococcal" isolates. {#h1.1}
------------------------------------------------------

All 64 NT "pneumococcal" isolates from three continents were positive for *lytA* and *ply* except for one isolate (MNZ1052), which had *lytA* but not *ply* ([Table 1](#tab1){ref-type="table"}). To exclude group I isolates, we used PCR to look for the presence of the *cpsA* gene. Twelve isolates had *cpsA* and were thus identified as group I isolates. The remaining 52 isolates were thus identified as group II isolates and chosen for additional studies ([Table 1](#tab1){ref-type="table"}).

###### 

Characterization of null-capsule (group II) "pneumococcal" isolates^[a](#ngtab1.1)^

  ID code       Source          Diagnosis   PCR result for:   NC clade            ST[^b^](#ngtab1.2)   GenBank accession no.                                                 
  ------------- --------------- ----------- ----------------- ------------------- -------------------- ----------------------- ------ ---- ------- ------------------------- ----------
  **MNZ11**     South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    **6151**                  JF489996
  MNZ15         South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    1106                       
  **MNZ24**     South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    **6152**                   
  **MNZ37**     South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    **1106**                  JF489997
  MNZ50         South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    1106                       
  MNZ66         South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    1106                       
  **MNZ67**     South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    **1464**                  JF489998
  MNZ75         South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    1106                       
  MNZ731        South Korea     CAR         \+                \+                  −                    −                       ND     \+   NCC1    1106                       
  MNZ5          South Korea     CAR         \+                \+                  \+                   \+                      1.5    ND   NCC2a   448                        
  **MNZ14**     South Korea     CAR         \+                \+                  \+                   \+                      1.5    −    NCC2a   **448**                   JF489999
  MNZ49         South Korea     CAR         \+                \+                  \+                   \+                      1.5    ND   NCC2a   448                        
  MNZ814        United States   CONJ        \+                \+                  \+                   \+                      1.5    ND   NCC2a   448                       JF490003
  MNZ815        United States   CONJ        \+                \+                  \+                   \+                      ND     ND   NCC2a   448                        
  MNZ816        United States   CONJ        \+                \+                  \+                   \+                      ND     ND   NCC2a   448                        
  MNZ817        United States   CONJ        \+                \+                  \+                   \+                      ND     ND   NCC2a   448                        
  MNZ818        United States   CONJ        \+                \+                  \+                   \+                      1.5    ND   NCC2a   448                       JF490004
  MNZ084        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ105        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ106        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ109        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ112        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ115        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  **MNZ085**    Brazil          CAR         \+                \+                  \+                   \+                      1.5    ND   NCC2a   **2315**                  JF490000
  MNZ089        Brazil          CAR         \+                \+                  \+                   \+                      1.5    ND   NCC2a   2315                      JF490001
  MNZ090        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ095        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ104        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ107        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ113        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ114        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ121        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ122        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ125        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ127        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ130        Brazil          CAR         \+                \+                  \+                   \+                      1.5    ND   NCC2a   2315                      JF490002
  MNZ132        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  MNZ133        Brazil          CAR         \+                \+                  \+                   \+                      ND     ND   NCC2a   2315                       
  **MNZ41**     South Korea     CAR         \+                \+                  \+                   \+                      1.0    ND   NCC2b   **6153**                  JF490005
  MNZ43         South Korea     CAR         \+                \+                  \+                   \+                      1.0    ND   NCC2b   6153                       
  MNZ45         South Korea     CAR         \+                \+                  \+                   \+                      1.0    ND   NCC2b   6153                       
  **MNZ1053**   United States   HIV-CAR     \+                \+                  \+                   \+                      1.0    ND   NCC2b   **P1**                    JF490006
  **MNZ1065**   United States   HIV-CAR     \+                \+                  \+                   \+                      1.0    ND   NCC2b   **P2**                    JF490007
  **MNZ1050**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P3**                    JF490008
  **MNZ1049**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P4**                    JF723379
  **MNZ1054**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P5**                     
  **MNZ1051**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P6**                     
  **MNZ1056**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P7**                     
  **MNZ1063**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P8**                    JF723380
  MNZ1052       United States   HIV-CAR     \+                −^[c](#ngtab1.3)^   −                    \+                      ND     ND   NCC3    Unknown[^d^](#ngtab1.4)    
  **MNZ1055**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P9**                     
  **MNZ1064**   United States   HIV-CAR     \+                \+                  −                    \+                      ND     ND   NCC3    **P10**                    

 Bold type indicates isolates whose STs were used to create the neighbor-joining tree in [Fig. 1](#fig1){ref-type="fig"}. CAR, CONJ, and HIV-CAR, respectively, indicate that the isolates were obtained from the NP of healthy children, the eyes of patients with conjunctivitis, and the NP of HIV^+^ persons. ND, not done.

 P1 to P10 are the provisional sequence types of HIV-CAR isolates. P2 and P5 are single-locus variants of P1 and P4, respectively.

 PCR for *ply* was done twice for this sample.

 The ST of MNZ1052 is unknown because its *aroE* PCR yielded no product.

MLST patterns of the 52 group II NT isolates. {#h1.2}
---------------------------------------------

Some streptococcal species related to *S. pneumoniae* can also meet the traditional genetic or biochemical definitions used for *S. pneumoniae* ([@B14]--[@B16]). To determine if the 52 group II isolates are truly *S. pneumoniae*, we performed MLST for 51 NT isolates (the *ply*-negative isolate was excluded). Thirty-six isolates (21 Brazilian, 5 U.S. conjunctivitis, and 10 Korean isolates) had pneumococcal sequence types (STs) that have already been included in the database at <http://www.mlst.net> ([Table 1](#tab1){ref-type="table"}). All 21 isolates from Brazil belonged to ST2315, which shares four genetic loci with ST344. All 5 conjunctivitis isolates from the United States belonged to ST448, and 10 Korean isolates belonged to ST448 (3 isolates), ST1106 (6 isolates), or ST1464 (1 isolate). The remaining 5 Korean isolates belonged to new STs---ST6151 (1 isolate), ST6152 (1 isolate), and ST6153 (3 isolates)---but the new STs were single-locus variants of either ST1106 or ST344. However, all 10 isolates from HIV-positive patients ([Table 1](#tab1){ref-type="table"}) that were analyzed by MLST have sequences that were 1 to 5% divergent from those known for any pneumococci, and they were identified as non-*S. pneumoniae* by the typing scheme at <http://www.mlst.net>. MLST analysis was not performed with one *ply* isolate (MNZ1052).

To visualize the genetic relationship of our group II NT isolates within the mitis group, we constructed a neighbor-joining tree with the concatenated sequences of six of the seven MLST loci (excluding *ddl*) of the 17 isolates ([Table 1](#tab1){ref-type="table"}; [Fig. 1](#fig1){ref-type="fig"}). The 52 NT isolates expressed 17 different STs, and the 17 isolates were chosen to represent all the 17 STs. [Figure 1](#fig1){ref-type="fig"} contains two additional data points (110.58 and *S. mitis* B6) that were based on published sequences (GenBank accession no. FN568063 for *S. mitis* and Hathaway et al. \[[@B8]\] for 110.58) and were added to the figure for comparison. Locations for *S. pneumoniae*, *S. pseudopneumoniae*, *S. mitis*, and *S. oralis* species were defined in the neighbor-joining tree using the MLST sequences described in other studies ([@B17], [@B21], [@B23]). The tree showed that the 10 U.S. isolates from HIV-positive patients that were analyzed by MLST cluster with the *S. pseudopneumoniae* or *S. mitis* species ([Fig. 1](#fig1){ref-type="fig"}). No isolates clustered with *S. oralis*. In contrast, 41 of the 52 isolates were clearly localized within *S. pneumoniae*. Due to duplicated MLST results, there were only 7 distinct STs among the 41 isolates clustering with *S. pneumoniae* ([Fig. 1](#fig1){ref-type="fig"}).

![A neighbor-joining tree of the MLST sequences of various species in the mitis group in published studies (all open symbols and two solid symbols) and from our study (remaining solid symbols). The two solid symbols from published studies are labeled 110.58 (ST344) ([@B8]) and *S. mitis* B6 (GenBank accession no. FN568063). Data from published studied were used to provide reference points. The symbols indicate *S. pneumoniae*, *S. pseudopneumoniae*, *S. mitis*, NCC1, NCC2, and NCC3. The two short arrows indicate strains MNZ1053 and MNZ1065, which express NCC2b (Table 1). The 52 group II NT isolates contained only 17 unique STs (bold letters in Table 1), and the 17 unique STs are shown in the tree. The tree was constructed with the concatenated sequence (2,751 bp) of 6 of the 7 DNA loci used for MLST by using the method for minimum evolution. The bar indicates 0.005 substitution per site. Bootstrap values are shown for each branch.](mbo0021212650001){#fig1}

Testing the 52 NT isolates with PCR for *aliC* and *aliD* genes and intergenic region. {#h1.3}
--------------------------------------------------------------------------------------

The *cps* sequences of four group II NT "pneumococcal" isolates have been reported ([@B8]). These four sequences are distinguished by the presence of *aliC* and *aliD* genes and also by the size of the intergenic region between the *capN*-like gene and *aliA* ([@B8]) ([Fig. 2](#fig2){ref-type="fig"}). To investigate heterogeneity among our 52 group II NT "pneumococci," we developed PCR tests for *aliC*, *aliD*, and the intergenic region. Their amplicons are, respectively, designated regions A, B, and C ([Fig. 2](#fig2){ref-type="fig"}). Using the PCR tests, we found nine Korean isolates lacking *aliC*, *aliD*, and the intergenic region and assigned them to null capsule clade 1 (NCC1). The PCR tests showed that three other Korean isolates, five U.S. isolates from conjunctivitis patients, and all 21 Brazilian isolates had both *aliC* and *aliD* and long (1.5-kb) intergenic regions. This group was assigned to null capsule clade 2a (NCC2a). In contrast, three additional isolates from South Korea and two U.S. isolates from HIV patients had both *aliC* and *aliD* but had short (1.0-kb) intergenic regions. This group was assigned to the null capsule clade 2b (NCC2b). Finally, nine U.S. isolates obtained from the NP of HIV-positive patients had *aliD* but not *aliC*, and their intergenic regions were variable in size (ranging from 1 to 2 kb). They were assigned to the null capsule clade 3 (NCC3).

![Diagrammatic representation of the *cps* regions of unencapsulated strains. *aliC*, *aliD*, and *cap* indicate *aliB*-like ORF1, *aliB*-like ORF2, and the *capN*-like region, respectively ([@B8]). *tnp* denotes a transposon-like insert. The *cps* regions were sequenced and analyzed for MNZ11, MNZ37, and MNZ67 in NCC1; MNZ14, MNZ41, MNZ85, MNZ89, MNZ130, MNZ814, MNZ818, MNZ1053, and MNZ1065 in NCC2; and MNZ1049, MNZ1050, and MNZ1063 in NCC3. Diagrams of the published sequences of 110.58 (NCC2a), 104.72 (NCC2b), 208.56 (NCC3), and *S. mitis* B6 (NCC3) (GenBank accession no. AY653209 to AY653212 and FN568063) are shown for comparison purpose. The numbers of bases in parentheses are the complete sequence sizes. MNZ1049 and MNZ1063 *cps* sequences are incomplete due to technical problems encountered during repeated sequencing attempts; their size estimates are based on electrophoresis of their PCR products.](mbo0021212650002){#fig2}

Genetic heterogeneity among NCC2a, NCC2b, and NCC3 isolates. {#h1.4}
------------------------------------------------------------

To better define the *cps* loci of the NCC2 and NCC3 isolates, we determined the DNA sequences of the PCR products from 12 representative isolates ([Table 1](#tab1){ref-type="table"}). [Figure 2](#fig2){ref-type="fig"} shows genetic diagrams of NCC2a, NCC2b, and NCC3 isolates along with those of published reference sequences. As expected, all NCC2 isolates have *aliC* and *aliD* as well as *capN*-like regions. Interestingly, the sequences of the three Brazilian NCC2a isolates (MNZ85, MNZ89, and MNZ130) are almost identical to the sequence of a European isolate (strain 110.58; accession no. AY653211). For example, our sequences of MNZ89, MNZ130, and MNZ85 have a 7,405-bp overlap with the published sequence of isolate 110.58. When the 7,405-bp sequences were compared, MNZ89, MNZ130, and MNZ85 differed from 110.58 by only 0, 2, and 5 nucleotides, respectively. The NCC2a isolates (MNZ14 from South Korea and MNZ814 and MNZ818 from the United States) with an \~10-kb PCR product ([Fig. 3](#fig3){ref-type="fig"}) have a 1.7-kb insert between *dexB* and *aliC*. Except for the insert region, the remainder of their *cps* loci (7,405 bp) was again almost identical (six nucleotide difference) to the corresponding *cps* region of 110.58 ([Fig. 2](#fig2){ref-type="fig"}). Thus, NCC2a isolates obtained from diverse geographic locations and in different years had very homologous *cps* sequences.

![Electrophoresis patterns of the PCR products of the *cps* regions of group II unencapsulated strains. PCR was performed with primer sets 5419 and 3419 (Table 2).](mbo0021212650003){#fig3}

The PCR products of the *cps* regions of three NCC2b isolates \[one Korean isolate (MNZ41) and two U.S. isolates (MNZ1053 and MNZ1065)\] were \~7.5 kb long. MNZ41 and MNZ1065 are shown in [Fig. 3](#fig3){ref-type="fig"}. Their sequences (6,935 bp) were \~97% identical to the published sequence of a European NCC2b isolate (strain 104.72; accession number AY653209) in all parts of the locus: 97% similar in *aliC*, 95% similar in *aliD*, and 94% similar in the 5′ region (835 bp) of the *capN*-like gene. When our three sequences were compared among themselves, the sequences for the two U.S. NCC2b *cps* regions were 99.8% identical to each other but were only 97.3% identical to the sequence for the Korean NCC2b *cps* region. Thus, while the general organizations of the *cps* regions of the NCC2b isolates are similar to those of NCC2a isolates, the NCC2b isolates have more sequence diversity.

As expected from their PCR test results, the sequencing studies with four NCC3 isolates showed them to have *aliD* and *capN*-like regions but not *aliC* regions. While the *capN*-like region was intact in one isolate (MNZ1050), sequencing of the region could not be completed for other isolates due to technical difficulties in sequencing ([Fig. 2](#fig2){ref-type="fig"}). Nevertheless, the sequences of our NCC3 isolates resemble those of isolate 208.56 from Europe and the *S. mitis* B6 genome ([Fig. 2](#fig2){ref-type="fig"}). When the *cps* locus of MNZ1050 is compared with the corresponding region of the *S. mitis* strain B6 genome (accession number NC013853), they are \~93% identical for bp 1 to 5060 except for 149-bp and 106-bp deletions at the ends of the *capN*-like gene ([Fig. 2](#fig2){ref-type="fig"}). Interestingly, genetic deletions are common in the NCC3 *cps* locus. For example, MNZ1049 and MNZ1054 have an incomplete *aliD* due to a 362-bp deletion. Thus, NCC3 isolates display much more *cps* sequence diversity than do NCC1 or NCC2 isolates.

Discovery of *pspK* among NCC1 isolates. {#h1.5}
----------------------------------------

To begin investigating the *cps* loci of the nine NCC1 isolates from South Korea, we determined the size of their *cps* regions using PCR primers located in the *dexB* and *aliA* genes. We found that their PCR products measured \~5 kb. The PCR products from isolates MNZ37, MNZ11, and MNZ67 with different MLST types are shown in [Fig. 3](#fig3){ref-type="fig"}. In contrast, the PCR products of the NCC2 isolates were three different sizes (7.5, 8, and 10 kb), and those of the NCC3 isolates were two different sizes (4 and 5 kb). We then obtained DNA sequences of the PCR products of the three Korean NCC1 isolates (GenBank accession numbers JF489996 to JF489998). As seen in the genetic diagram in [Fig. 2](#fig2){ref-type="fig"}, the NCC1 *cps* region of MNZ37 has no typical genes involved in capsule biosynthesis (e.g., *cpsA*), but it contains a 1,410-bp insertion sequence and a 1,605-bp novel open reading frame (ORF) ([Fig. 2](#fig2){ref-type="fig"}). The insertion sequence is named IS1202, since its sequence is 98% identical to the IS1202 found in the *cps* locus of the *S. pneumoniae* strain 361/39 (serotype 35F; accession number CR931707). The novel ORF was found in all 9 NCC1 isolates, and the presence of the novel ORF was included in the definition of NCC1 here.

Analysis of the novel ORF showed that it likely encodes a 534-amino-acid (aa) polypeptide with a signal peptide at the N-terminal region, a long alpha-helix region in the middle (between residues 40 and 475), and an LPXTG motif at the C-terminal region ([Fig. 4](#fig4){ref-type="fig"}). This finding suggests that the novel ORF encodes a surface protein that is secreted and anchored to peptidoglycan. The ORF was named pneumococcal surface protein Korea (*pspK*). The alpha-helix region (residues 40 to 475) has two interesting subregions. One subregion (residues 203 to 280) is 67% and 76% identical, respectively, to the R1 (residues 197 to 274) and R2 (residues 350 to 427) domains of PspC/CbpA of *S. pneumoniae* TIGR4 (accession number NP_346601), which appear to be involved in pneumococcal adhesion to and invasion of human cells ([@B24]) and have YPT sequences. The YPT motif is known to be critical in binding human pIgR or secretory component ([@B25]) and is also found in the R1-like region of PspK. The other interesting subregion (residues 280 to 475) has 26 repeats containing 7 to 8 amino acids per repeat. The repeat sequence is typically (E)EEAKRKA or (E)EEAKQKA and generally has residues with opposite charges at the *i*th and (*i* + 4)th positions, which can stabilize the alpha-helix region ([@B26], [@B27]).

![Predicted amino acid sequence of the ORF of PspK from MNZ37 (A) and schematic diagram of the PspK of MNZ37 (B). The ORF encodes a 534-aa polypeptide with a signal peptide (1 to 31), an alpha-helical region (39 to 475), and an LPXTG motif. The alpha-helical region from bases 113 to 279 resembles the R1 domain of *pspC* and has a YPT motif, which is associated with binding to the human secretory component. The repeat region between bases 279 and 475 has 26 repeats of (E)EEAK(R/Q)K.](mbo0021212650004){#fig4}

Nasopharyngeal colonization by NCC1 and NCC2 isolates. {#h1.6}
------------------------------------------------------

Previous studies using laboratory-derived strains of acapsular *S. pneumoniae* found that capsule expression is important or even essential in NP carriage in mice ([@B28]--[@B30]). In view of our finding that naturally acapsular *S. pneumoniae* isolates readily colonize NP of children ([@B13], [@B31], [@B32]), we tested the abilities of two naturally acapsular strains (MNZ11 of NCC1 and MNZ85 of NCC2) to colonize NP of mice using the previously established mouse model ([@B28], [@B33]--[@B35]). For comparison, we also did colonization studies with three strains (D39, AM1000, and R36A) that have been used in previous colonization studies. Similar results were obtained in two different experiments ([Fig. 5](#fig5){ref-type="fig"}), and the combined results were used for data analysis.

![Nasopharyngeal carriage of *S. pneumoniae* in mice. C57BL/6 mice were inoculated with six *S. pneumoniae* strains (*x* axis), and pneumococci were recovered 5 days later from the nasal wash (A and B) and nasal tissue (C and D). Each group is identified with the names of the respective bacterial strains and descriptions of their *cps* loci. No mice died during the experiment, and each data point indicates an individual animal. Open symbols show results from the first experiment, and solid symbols show results from the second. The horizontal bars indicate the median for the group. The dotted lines indicate the detection limit, which is 40 CFU/mouse. Symbols below the dotted lines were arbitrarily placed to show individual data points. The Mann-Whitney test was used to obtain *P* values.](mbo0021212650005){#fig5}

Consistent with the previous report ([@B28]), nasal washes contained many D39 colonies (median, 2,040 CFU/mouse) but very few colonies (median, 40 CFU/mouse or less) of AM1000 which is a recent unencapsulated variant of D39 (Fig. 5A), and the difference was statistically significant (*P* = 0.002). Also, R36A, another laboratory-derived acapsular variant of D39, was not detectable (\<40 CFU/mouse) in nasal washes. In contrast, the two naturally acapsular strains, MNZ11 and MNZ85, were present in the nasal washes of mice (Fig. 5A), and their median numbers of CFU were 3,340 (*P* = 0.96 compared with D39) and 540 (*P* = 0.0314 compared with D39), respectively. The difference between MNZ85 and D39 carriages was significant (*P* = 0.0314). When the CFU in the nasal tissue were compared, similar relative patterns were observed, but this time there was no significant difference in the numbers of CFU of MNZ85 and D39 (Fig. 5C). Moreover, pneumococcal infection in all mice was limited to the NP, since no bacteria were found in the blood or lungs of infected mice of all groups (data not shown). This is consistent with the results of previous studies of carriage in the absence of induced aspiration, where the CFU are generally either not detectable or present in much lower numbers in the lungs than in the nasal wash or nasal tissue ([@B35], [@B36]).

To confirm the role of *pspK* in NP carriage, we prepared a new strain, MNZ1131, by deleting *pspK* from MNZ11 and examined both strains for colonizing mouse NP. Nasal washes of mice infected with the wild-type strain (MNZ11) contained many bacteria (median, 1,180 CFU/mouse), but very few bacteria (median, ≤40 CFU/mouse) were detected in the washes of MNZ1131-infected mice (*P* = 0.0048) ([Fig. 5B](#fig5){ref-type="fig"}). When the nasal tissues were compared, MNZ11 tended to colonize better than MNZ1131 (median, 640 versus 100 CFU/mouse) without achieving statistical significance (*P* = 0.106) ([Fig. 5D](#fig5){ref-type="fig"}). Taking these results together, we conclude that naturally acapsular pneumococci can colonize NP of mice and that *pspK* appears to be essential to the colonization.

DISCUSSION {#h2}
==========

Because of its pathogenic importance, the pneumococcal capsule has been extensively studied ([@B37]--[@B39]), and the identification of capsule types is considered important. In contrast, characterization of NT "pneumococcus" is usually limited to simple serologic tests, even though NT "pneumococcus" is known to cause infectious conjunctivitis ([@B7], [@B12], [@B40]) or even IPD ([@B8]). Such a simple serologic definition of NT "pneumococcus" is inadequate, since it may include (i) *S. pneumoniae* strains expressing rare, so-far-unidentified capsule types; (ii) *S. pneumoniae* strains with disrupted and nonfunctional *cps* loci (group I); (iii) *S. pneumoniae* strains with novel genes at their *cps* loci (group II); or (iv) streptococcal species closely related to but different from *S. pneumoniae*.

The last possibility is clearly illustrated with our NCC3 isolates and two NCC2b isolates from HIV patients attending the same clinic. Although they have the key features of *S. pneumoniae* (e.g., *lytA* or optochin sensitivity), they belong to the pneumococcus-like species *S. pseudopneumoniae* or *S. mitis*. Our finding is consistent with a report that states that NT "pneumococcal" isolates from HIV^+^ patients are not usually *S. pneumoniae* (i.e., 11 of 12 isolates in that study were not *S*. *pneumoniae*) ([@B21]), and healthy children can carry NCC3 isolates belonging to *S. pneumoniae* ([@B41]). In addition, our NT "pneumococcal" isolates from HIV^+^ patients have diverse MLST types and different *cps* sequences, suggesting that each isolate arose individually. Perhaps HIV^+^ patients provide a special environment where these pneumococcus-like isolates can arise from a vast pool of commensal species.

In contrast, NCC2a isolates were all revealed to be *S. pneumoniae* ([Table 1](#tab1){ref-type="table"}) and also showed clear evidence of spreading. We found that many Brazilian children carry pneumococcal NCC2a isolates with an identical sequence type (ST2315) as well as *cps* loci. Indeed, NCC2a isolates have been associated with epidemic conjunctivitis in the past ([@B7]). Our finding almost identical *cps* sequences among many NCC2a isolates from diverse geographic locations, times, and diseases, as well as with different MLST types, suggests that isolates with NCC2a *cps* can readily spread among individuals. As NCC2a isolates account for the majority (29 of 52) of group II NT "pneumococcal" isolates and have been shown to cause IPD ([@B8]) as well, further studies are needed to understand their ability to spread and cause disease.

A surprising finding was the discovery of a new clade, NCC1, and its unique gene, *pspK*. MLST analysis clearly shows NCC1 isolates to be typical *S. pneumoniae*. While additional epidemiological studies are necessary to know their full pathogenic potential, all NCC1 isolates identified so far have been carriage isolates. The NCC1 isolates are clearly communicable, since NCC1 isolates expressing one MLST type are found among children living in different cities in South Korea. Several features of *pspK* suggest that it encodes a surface protein important in cell adhesion. PspK has an alpha helix with highly charged amino acids \[(E)EEAKRKA\], which may serve as a rigid stalk for the R1-like region of PspC. The R1-like region of PspC is known to be important in cell adhesion ([@B24], [@B42]). In addition to these molecular features, we have directly demonstrated that an NCC1 isolate can colonize NP of mice only when it has *pspK*. Thus, PspK may facilitate pneumococcal adhesion to host cells, as does PspC ([@B24], [@B42]).

Mutations that block capsule expression in normally encapsulated strains have been reported to block nasal colonization ([@B28]--[@B30]), demonstrating that for these strains, the capsule is a critical colonization factor. In contrast, we show that NCC1 and NCC2a isolates spread and colonize the NP of many different children and that they can also colonize mice. Thus, expression of a PS capsule is not an absolute requirement for NP colonization of pneumococci, and naturally acapsular strains may have genes like *pspK* that provide critical survival advantages in the NP, compensating for the lack of a capsule. The survival advantages of such proteins may be novel and could lead to increased colonization by several different mechanisms, including increased hydrophilicity of the bacteria to prevent them from clumping and being swept out by mucus, increased adherence to epitopes on host cells, and/or more extensive biofilm formation. Studies of naturally acapsular *S. pneumoniae* strains may show us novel mechanisms of pneumococcal survival in the nasopharynx.

MATERIALS AND METHODS {#h3}
=====================

Bacteria. {#h3.1}
---------

From three different countries (South Korea, Brazil, and the United States), we obtained 64 anonymized noninvasive isolates that had been identified as NT "pneumococci" in previous studies ([@B31], [@B43], [@B44]). Sixteen Korean isolates were obtained from the nasopharynges (NP) of healthy children (less than 5 years old) attending daycare centers (DCCs) in 2008 ([@B43]). Twenty-six Brazilian isolates were obtained from the NP of children (less than 5 years old) attending municipal DCCs in 2005 ([@B31], [@B45]). The 22 isolates from the United States included 5 isolates from patients with conjunctivitis (provided by Mary Marquart at the University of Mississippi Medical Center, Jackson, MS) and 17 isolates from the nasopharynges of HIV-positive outpatients (\>18 years old) at a large academic referral clinic ([@B44]). All 64 isolates were identified as pneumococci by commonly used methods, such as colony morphology, alpha-hemolysis, optochin sensitivity, and bile solubility, and determined to be NT by the Quellung reaction. They tended to form smaller colonies than encapsulated pneumococci.

Strain R36A was obtained from D. Briles (University of Alabama at Birmingham, Birmingham, AL). Strains D39 and AM1000 were obtained from J. Yother (University of Alabama at Birmingham, Birmingham, AL). AM1000 was derived from D39 by disrupting its *cps* locus and does not express capsular PS ([@B28]). The three strains were previously used by the above laboratories in nasopharyngeal carriage experiments ([@B28], [@B46]). A *pspK* deletion mutant strain (MNZ1131) was created as follows. The 5′ and 3′ flanking regions of *pspK* were obtained by PCR using MNZ11 as the template and primer pairs 5419-3743 and 5743-3419, respectively ([Table 2](#tab2){ref-type="table"}). A spectinomycin resistance cassette (*aad9* gene) was obtained by PCR from plasmid vector pCLT1242 ([@B47]) using primers 5725 and 3725 ([Table 2](#tab2){ref-type="table"}). The three DNA fragments were joined to an \~4.8-kb DNA fragment by an overlap extension PCR ([@B48]). MNZ1131 was obtained by transforming MNZ11 with the \~4.8-kb DNA and selecting a spectinomycin-resistant isolate. Correct insertion of *aad9* and deletion of *pspK* were confirmed by sequencing the involved region of MNZ1131 DNA. All isolates were grown in Todd-Hewitt broth supplemented with 0.5% yeast extract (THY) and stored at −80°C in 20% glycerol.

###### 

Primers used in this study

  Primer            Genetic location                              Sequence (5′ → 3′)                     Reference
  ----------------- --------------------------------------------- -------------------------------------- ------------
  Forward primers                                                                                        
   5120             *dexB*                                        TGTCCAATGAAGAGCAAGACTTGACAGTAG         [@B5]
   5419             *dexB*                                        TCTTAGTTCCATGGGATGCTTTCTGTGTG          [@B8]
   5322             *lytA*                                        CAACCGTACAGAATGAAGCGG                  [@B53]
   5203             *ply*                                         ATTTCTGTAACAGCTACCAACGA                [@B54]
   5202             *cpsA*                                        GCAGTACAGCAGTTTGTTGGACTGACC            [@B55]
   5441             Intergenic region between *capN* and *aliA*   CGTTCTGCGACTGACCTTCC                   This study
   5433             *aliC*                                        AACACTTGGAACGGAGAATG                   [@B8]
   5434             *aliD*                                        AGATGCCAAATGGTTCACGG                   [@B8]
   5658             *pspK*                                        GCAAATCAGCCAGTAACTGTGA                 This study
   5725             *aad9*                                        TTTTCCTTGATTCGATTTTCGTTCGTGAATAC       This study
   5743             *pspK*                                        TATTGCAGACAGCTTGTTAAACATAAA            This study
  Reverse primers                                                                                        
   3126             *aliA*                                        CAATAATGTCACGCCCGCAAGGGCAAGT           [@B5]
   3419             *aliA*                                        CGCTGAACTTTTGTAGTTGCTGTCTGGTCAAC       [@B8]
   3322             *lytA*                                        TTATTCGTGCAATACTCGTGCG                 [@B53]
   3203             *ply*                                         GAATTCCCTGTCTTTTCAAAGTC                [@B54]
   3202             *cpsA*                                        GAATATTTTCATTATCAGTCCCAGTC             [@B55]
   3403             Intergenic region between *capN* and *aliA*   GCTAAAACACCAGCTGCTAA                   This study
   3433             *aliC*                                        GCCCTTTGTTATACCTAGATGTTTC              [@B8]
   3434             *aliD*                                        GAAATCTTTTAACAAATAAGGTCCG              [@B8]
   3658             *pspK*                                        CAAGATAAGCTTTCTGCACCTCT                This study
   3725             *aad9*                                        GGGAAATATTCATTCTAATTGGTAATGCAGACAGCT   This study
   3743             *pspK*                                        CGAATCAAGGAAAAATATTCTTATTATTCAT        This study

Multilocus sequence typing (MLST). {#h3.2}
----------------------------------

PCR for MLST was performed as described elsewhere ([@B49]), and the DNA sequences of the PCR products were determined by the Genomics core facility at University of Alabama at Birmingham (UAB). All the DNA sequences were submitted to the pneumococcal MLST website (<http://spneumoniae.mlst.net>), which identified the sequences either as existing alleles or as new alleles with new allele numbers.

A neighbor-joining tree ([Fig. 1](#fig1){ref-type="fig"}) was created with concatenated DNA sequences (2,751 bp) of six of the seven genetic loci used by MLST (*ddl* was removed) for the 17 NT pneumococcal isolates using MEGA version 4 ([@B50]). The sequence types of these 17 isolates are in bold in [Table 1](#tab1){ref-type="table"}. To include reference pneumococcal and nonpneumococcal species in the tree, the corresponding DNA sequences of 39 *S. pneumoniae* strains, 42 *S. pseudopneumoniae* strains, 25 *S. mitis* strains, and 8 *S. oralis* strains were retrieved from the GenBank or the MLST database. The sequences in these two databases were deposited by others ([@B17], [@B21], [@B23]). The statistical significance of a branching was determined by performing 1,000 bootstrap replications with the minimum evolution algorithm. The tree was drawn to scale, with branch lengths measured in the same units used for the evolutionary distances on the phylogenic tree.

PCR for pneumococcus-specific genes and sequencing of the *cps*. {#h3.3}
----------------------------------------------------------------

To detect genes encoding pneumococcal autolysin (*lytA*), pneumolysin (*ply*), *cpsA* (*wzg*), *aliC*, *aliD*, *pspK*, and the intergenic region, PCR was performed as described elsewhere ([@B51]) with the primer sets listed in [Table 2](#tab2){ref-type="table"}. The PCR products were visualized by agarose gel electrophoresis ([@B51]). To amplify the entire *cps* locus, a long-range PCR was carried out using the primers located at *dexB* and *aliA* ([Table 2](#tab2){ref-type="table"}) with TaKaRa LA Taq (TaKaRa Bio United States, Madison, WI).

The DNA sequences of the PCR products were determined by the Genomics Core Facility at UAB. The DNA sequences were analyzed and aligned using DNASTAR Lasergene version 6.0. Insertional sequences and the open reading frames (ORFs) in the DNA sequences were identified using a BLAST search at the National Center for Biotechnology Information website (<http://www.ncbi.nlm.nih.gov/BLAST>), Softberry (<http://www.softberry.com>) free web-based software, and IS Finder (<http://www-is.biotoul.fr>).

Nasopharyngeal colonization by pneumococci in mice. {#h3.4}
---------------------------------------------------

Pneumococcal carriage in mice was examined as previously described ([@B28], [@B33], [@B35], [@B52]). Eight-week-old C57BL/6 mice were obtained from Frederick Cancer Research UK (Baltimore, MD), and 10 µl of Ringer's lactate solution containing bacteria was instilled into their nares without anesthesia in two separate experiments ([Fig. 5A and C](#fig5){ref-type="fig"}). Inoculating doses (CFU per mouse) were 1.5 × 10^7^ for R36A, 9 × 10^6^ for AM1000, 6 × 10^6^ for D39, 3 × 10^7^ for MNZ11, and 2 × 10^7^ for MNZ85 in the first experiment. In the second experiment, they were 1.8 × 10^7^ for R36A, 5 × 10^6^ for AM1000, 5 × 10^6^ for D39, 4.3 × 10^7^ for MNZ11, and 2.7 × 10^7^ for MNZ85. In a prior colonization study we demonstrated that the bacterial dose affected the frequency of mice with detectable colonization but had essentially no effect on the numbers of CFU in colonized mice ([@B35]). These doses are thus well within an acceptable range for comparison. After 5 days, the mice were sacrificed, and nasal wash samples were obtained by washing the nasal cavity with 1 ml of Ringer's lactate solution. The nonwashable bacterial fraction was obtained by grinding the excised nasal tissue in 1 ml of Ringer's lactate solution. The nasal washes and nonwashable fractions were serially diluted and plated on blood agar plates with 50 µg/ml of gentamicin. After overnight inoculation at 37°C with 5% CO~2~, the number of colonies in each plate was determined.

To study the involvement of *pspK* in NP carriage in mouse, additional experiments were performed exactly as described above with a Δ*pspK* strain (MNZ1131) and a wild-type strain (MNZ11) ([Fig. 5B and D](#fig5){ref-type="fig"}). The inoculating doses were 1.2 × 10^7^ CFU of MNZ11 and 4.5 × 10^7^ CFU of MNZ1131 in the first experiment and 3 × 10^7^ CFU of MNZ11 and 1.8 × 10^7^ CFU of MNZ1131 in the second experiment.

Statistical analysis. {#h3.5}
---------------------

CFU in different experimental groups were compared using the Mann-Whitney test and Prism 4 software (GraphPad Software, Inc., San Diego, CA).

Nucleotide sequence accession numbers. {#h3.6}
--------------------------------------

The 12 DNA sequences determined here were registered in GenBank (accession numbers JF489999 to JF490008, JF723379, and JF723380).
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Salter et al. (Microbiology, 8 March 2012, posting date, doi:10.1099/mic.0.056580-0) described the gene *nspA* among NT pneumococcal isolates from Thailand and the Netherlands. It is likely that *nspA* is identical to *pspK*.
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